| ORIGINAL ARTICLE |
|
| Year : 2009 | Volume
: 30
| Issue : 2 | Page : 84-88 |
|
|
A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients
Neerja Puri
Department of Pediatric Medicine, Medical College and Hospital, Kolkata, India
Correspondence Address:
Neerja Puri
C/o Dr Asha Puri, House No 626, Phase II, Urban Estate, Dugri Road, Ludhiana, Punjab
India
DOI: 10.4103/0253-7184.62763 PMID: 21938126
|
|
|
The clinical effect of imiquimod stems from cytokine-induced activation of the immune system. A randomized study was conducted to study the efficacy and safety of daily applications of 5% imiquimod cream in female patients with external genital warts and molluscum contagiosum (MC). The clearance rate of lesions was 75% in genital MC patients and 50% in patients with genital warts. Erythema was the commonest adverse reaction seen in 24% patients with the use of 5% imiquimod. Other side effects were excoriation seen in 16% patients, erosions in 10% patients, excoriation in 6% patients and pain was seen in 4% patients. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
